COLLCollegium Pharmaceutical, Inc.

Healthcare

$22.06-38% 1Y

$22.06

$21.8552 weeks$49.84

Is it growing?

Excellent

Growing: revenue growing +14% year on year, earnings up +19% year on year, and operating margin widening (+0.8 points).

3 good

Revenue trend+14% in a year

Trailing-twelve-month revenue vs a year earlier, from the company's own filings. Five-year pace: +20% a year.

Earnings trend+19% in a year

Trailing-twelve-month earnings per share against a year earlier. Growing faster than revenue, so margins or the share count are helping.

Margin direction+0.8 points operating

Trailing-twelve-month operating margin, 19.3% now against 18.4% a year earlier.

All from SEC EDGAR, as of Jun 30, 2026.

Against the whole market›

Percentile against every name Ryufin tracks. Higher is better; the tick marks the middle of the market. Context, not one of the checks above.

Revenue growth, 3 yearsbetter than 79% of the market

Where this answer is blind. These are trailing numbers from the filings, not forecasts: an acquisition or a one-off year can flatter them, so check the quarters.

Is COLL growing?

Collegium Pharmaceutical, Inc. has grown revenue 15% a year over three years and 20% a year over five.

+15%

Revenue growth, 3-year annual rate · Drug Manufacturers - Specialty & Generic median +13% · steady growth, ahead of inflation · compounded from trailing twelve-month revenue

Revenue growth, 5-year rate: +20%
Revenue growth, 5-year rate · +15% over three · growth has slowed since the five-year average
Years of annual history on file: 13
Years of annual history on file · FY2013 to FY2025, as filed

Details›